A multi-site clinical trial spearheaded by the University of Minnesota Medical School and School of Public Health has revealed that patients consuming the diabetes drug metformin would lower their chance of emergency hospitalization or death due to Covid-19 by 40 % - 50 %.

As the U.S. continues the Covid-19 vaccine rollout, many parents are paying attention to the effects of the vaccines. Invisibly used it’s Realtime Research tool to poll 1258 Americans to find out public sentiment on the topic, and learn if parents are vaccinating their kids and if so, when they plan to do it.

People who received at least one influenza vaccine were 40 percent less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UT Health Houston.

Before the introduction of the vaccine, people with certain inflammatory immune conditions may have been at high risk of death if they contracted Covid-19, suggests a new study by the London School of Hygiene & Tropical Medicine.

To confront the many challenges that infectious diseases pose to mankind head-on, a multi-disciplinary team of bioengineers, materials-scientists and immunologists at Harvard’s Wyss Institute has developed a broadly deployable biomaterials-based infection vaccine technology called “Omnivax.”

Under a 15-year strategic collaboration agreement signed between Moderna and Thermo Fisher Scientific, both the firms will work together to ensure large-scale manufacturing of Moderna’s Covid-19 vaccine, and other investigational mRNA drugs in the USA.

The European Commission published an interactive map showcasing Covid-19 vaccine production capacities in the EU, along the entire supply chain.

German biopharmaceutical company Biontech announced plans for the development of the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022.

During the Covid-19 pandemic, cloth face masks became a way to help protect yourself and others from the virus. And for some people, they became a fashion statement, with many fabric choices available. But just how effective are they, especially in containing a sneeze?

BD (Becton, Dickinson and Company), a global medical technology company, will build a € 165 million ($ 200 million) high-tech manufacturing facility in city of Zaragoza, Spain, for the production of drug delivery devices.